Synairgen Research Ltd.
6 clinical trials · Sponsor
◉ Watch Synairgen Research Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection (NCT06999603) | Synairgen Research Ltd. | 2025-09-02 |
| Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity (NCT05207293) | Synairgen Research Ltd. | 2021-11-15 |
| Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 (NCT04732949) | Synairgen Research Ltd. | 2021-01-12 |
| Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection (NCT04385095) | Synairgen Research Ltd. | 2020-03-16 |
| A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza (NCT03570359) | Synairgen Research Ltd. | 2018-01-29 |
Track Synairgen Research Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.